Clinical Trial Update: Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine [NA]

View source ↗

Summary

This completed clinical trial evaluated tumor factors in breast cancer patients treated with docetaxel and capecitabine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Breast Cancer | NA | Status: COMPLETED